1. Home
  2. |Insights
  3. |ASBCA's FY15 Report – a Look at the Numbers

ASBCA's FY15 Report – a Look at the Numbers

Client Alert | less than 1 min read | 11.05.15

Last month, the Armed Services Board of Contract Appeals published its FY15 Report of Transactions and Proceedings, which provides statistics regarding the adjudication of appeals between contractors and the Army, Navy, Air Force, Corps of Engineers, DLA, DCMA, CIA, NASA, other Defense agencies, and the Washington Metropolitan Area Transit Authority. This year's report reflects that the appellant prevailed in just over half of the appeals decided in the merits (53%) and indicates that, as usual, the board had a high success rate in resolving matters via ADR, with a 93% resolution in non-binding ADR.


Insights

Client Alert | 3 min read | 05.26.26

pH, Prosecution History Estoppel, and Patent Scope: Three Lessons from the Federal Circuit's Latest Hatch-Waxman Ruling

On May 13, 2026, the U.S. Court of Appeals for the Federal Circuit affirmed a district court judgment of no infringement in Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc., No. 24-1641. The decision offers important guidance for patent holders and generic manufacturers on the role of industry standards in interpreting scientific terminology during claim construction, prosecution history estoppel, and the disclosure-dedication rule....